June 17, 2021 10:32 AM EDTUpdated 11:19 AM
Pharma

Bay­er clos­ing down San Fran­cis­co re­search hub as at­ten­tion turns to Berke­ley plan

Max Gelman

Senior Editor

Bay­er is say­ing farewell to a long­time re­search hub in San Fran­cis­co, cen­tral­iz­ing US ef­forts in the Boston area and po­ten­tial­ly leav­ing sev­er­al biotechs in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Take­da to pay $200M for rights to ane­mia drug from Keros

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

Gilead makes an­oth­er ADC move, ink­ing up to $415M pact with Tubu­lis

Rev­o­lu­tion sells $600M in shares on back of RAS in­hibitor port­fo­lio up­dates

Scott Got­tlieb says he’s against RFK Jr. for HHS: ‘It will cost lives in this coun­try’

A service from the Financial Times